Why We’re Excited About Compass Pathways’ New Clinical Trial Treating PTSD with Psilocybin
Compass Pathways (Nasdaq: CMPS) has announced the launch of a…
mdma
Can the Psychedelics Boom Go Bust? A Conversation with Cybin Chief Clinical Officer Dr. Alex Belser
“Something that people used to speak about only in whispers is now standard policy,” says the psychedelics researcher, with 20 years of experience, in a wide-ranging Q&A.
Psychedelic Users Experienced Less Psychological Stress During COVID-19 Lockdowns, Study Finds
Researchers found stress further reduced for the participants that use psychedelic drugs at least once every six months.
Driver’s Licenses to Trip on Psychedelics by 2035? Rick Doblin Maps Out the Future of ‘Spiritualized Humanity’
The MAPS founder, who will speak at psychedelic conference Wonderland Miami next month, predicts clinics that administer the medicines will become licensing bodies for personal use.
Preventing Sexual Abuse in Psychedelic Therapy
Recent study interviews 23 underground psychedelic therapy practitioners about the biggest ethical issues and boundary challenges they face while sharing such an intimate space with clients.
Psychedelic Business Spotlight: October 1, 2021
This week in psychedelic business news: more evidence supporting ketamine for depression; a new use for MDMA; Lobe Sciences makes a leap in treating PTSD; Delix raises big bucks; and BetterLife Pharma patents solution for cluster headaches.
Mind Cure Health Targeting Hypoactive Sexual Desire Disorder with MDMA
“Women’s desire issues have not been adequately addressed to date, and we believe this treatment incorporating MDMA and psychotherapy has real promise,” says CEO Kelsey Ramsden
Psychedelics Helped Me Heal From Sexual Trauma and Research Shows I’m Not Alone
Reprocessing sexual trauma is a difficult task, but psychedelics are presenting themselves as a powerful tool to help survivors.
How Mind Medicine Australia Is Tackling Deadly Mental Health Crisis with Psychedelics
Charity co-founder Tania de Jong says Covid-19 pandemic has led to “a huge spike in mental health issues including, very sadly, suicides,” and she believes psychedelics are a solution.
TRIPP Acquires PsyAssist to Empower Psychedelic Therapies with Virtual Reality
Clinicians are currently using TRIPP to help immerse patients into alternative realities and to support patients’ wellbeing before, during, and after ketamine-assisted therapy.
End of content
End of content